Skip to main content
SpringerLink
Log in

The decision to use antithrombotics in patients with atrial fibrillation (AF) should be based on the risk of stroke,

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. American College of Cardiology, American Heart Association, European Society of Cardiology.Stroke risk should determine anti-clotting treatment for people with irregular heartbeat. Media Release: 2 Aug 2006. Available from: URL: http://www.acc.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The decision to use antithrombotics in patients with atrial fibrillation (AF) should be based on the risk of stroke,. Pharmacoecon. Outcomes News 509, 3 (2006). https://doi.org/10.2165/00151234-200605090-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605090-00007

Keywords

Search

Navigation